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Abstract. 
 
Recent studies have established cell type–
specific, proapoptotic, or antiapoptotic functions for 
the transcription factor NF-
 
k
 
B. In each of these studies, 
inhibitors of NF-
 
k
 
B activity have been present before 
the apoptotic stimulus, and so the role of stimulus-
induced NF-
 
k
 
B activation in enhancing or inhibiting 
survival could not be directly assessed. Sindbis virus, an 
alphavirus, induces NF-
 
k
 
B activation and apoptosis in 
cultured cell lines. To address whether Sindbis virus–
induced NF-
 
k
 
B activation is required for apoptosis, we 
used a chimeric Sindbis virus that expresses a superre-
pressor of NF-
 
k
 
B activity. Complete suppression of vi-
rus-induced NF-
 
k
 
B activity neither prevents nor poten-
tiates Sindbis virus–induced apoptosis. In contrast, 
inhibition of NF-
 
k
 
B activity before infection inhibits 
Sindbis virus–induced apoptosis. Our results demon-
strate that suppression of steady-state, but not stimulus-
induced NF-
 
k
 
B activity, regulates expression of gene 
products required for Sindbis virus–induced death. Fur-
thermore, we show that in the same cell line, NF-
 
k
 
B 
can be proapoptotic or antiapoptotic depending on the 
death stimulus. We propose that the role of NF-
 
k
 
B in 
regulating apoptosis is determined by the death stimu-
lus and by the timing of modulating NF-
 
k
 
B activity rel-
ative to the death stimulus.
 
M
 
ulticellular
 
 organisms use a programmed
process known as apoptosis to eliminate dam-
aged or unwanted cells during development, in
adulthood, or in disease states. In some instances, cells
destined to die by apoptosis must synthesize new mRNAs
encoding putative death proteins for ordered self-destruc-
tion to occur. Indeed, general inhibitors of transcription
and translation inhibit apoptotic death in response to a
host of stimuli, even when added many hours after the on-
set of the death stimulus (Martin et al., 1988; Oppenheim
et al., 1990; Ratan et al., 1994; Jacobson et al., 1997). A re-
quirement for transcription in the proper execution of
some types of apoptosis has stimulated a search for DNA-
binding proteins known as transcription factors that are
activated by apoptotic stimuli, and that govern expression
of putative death proteins (Jehn and Osborne, 1997). Sev-
eral apoptosis-associated transcription factors have been
identified, including p53 (Lowe et al., 1993), c-jun (Estus
et al., 1994; Ham et al., 1995), Nurr-77/Nor-1 (Liu et al.,
1994; Woronicz et al., 1994), and interferon regulatory fac-
tor-1 (Tanaka et al., 1994).
Recent data suggests that another transcription factor,
 
NF-
 
k
 
B, though classically associated with immune and in-
flammatory responses (Baeuerle and Henkel, 1994), can
also be added to the list of apoptosis-associated transcrip-
tion factors. The NF-
 
k
 
B family of transcription factors is
composed of five different subunits, including p50, p52,
p65/Rel A, c-Rel, and Rel-B, which can form either
homodimers or heterodimers (Baeuerle and Baltimore,
1996). Overexpression of one of these NF-
 
k
 
B subunits,
c-rel, in chick bone marrow cells leads to apoptosis (Ab-
badie et al., 1993). These observations suggest that in some
cell types, NF-
 
k
 
B activation is sufficient to activate the
apoptotic process. Additionally, inhibition of NF-
 
k
 
B activ-
ity using 
 
k
 
B-specific transcription factor decoys inhibits
Sindbis virus–induced cell death in AT-3 prostate carci-
noma cells (Lin et al., 1995). Moreover, overexpression of
a truncated dominant-negative form of p65/rel A inhibits
serum deprivation–induced NF-
 
k
 
B–dependent gene acti-
vation and apoptosis in human embryonic kidney cells
(Grimm et al., 1996). These results identify apoptotic par-
adigms where NF-
 
k
 
B activation is necessary for cell death
initiation, and confirm that NF-
 
k
 
B can act as a proapop-
 
Address all correspondence to Rajiv R. Ratan, M.D., Ph.D., Neurology
Laboratories at Beth Israel Deaconess Medical Center, Harvard Institutes
of Medicine, Rm. 857; 77 Avenue Louis Pasteur, Boston, MA 02115.
  
The Journal of Cell Biology, Volume 141, 1998 1480
 
totic transcription factor. Indeed, several proapoptotic
genes, including c-Myc (La Rosa et al., 1994), p53 (Wu and
Lozano, 1994), Fas ligand (Takahashi et al., 1994), and in-
terleukin-1 
 
b
 
–converting enzyme (caspase-1; Casano et al.,
1994) have NF-
 
k
 
B–binding sequences in their promoter
regions.
In contrast to the aforementioned observations, NF-
 
k
 
B
activity appears to regulate genes that suppress some types
of apoptosis. For example, suppression of NF-
 
k
 
B activity
in immature B cells after adding anti-IgM (Wu et al.,
1996); in cells stimulated with TNF-
 
a
 
, radiation, or dauno-
rubicin (Liu et al., 1996; Beg and Baltimore, 1996; Wang
et al., 1996; van Antwerp et al., 1996); or in liver during de-
velopment (Beg et al., 1995); dramatically enhances cell
death. Putative NF-
 
k
 
B–regulated antiapoptotic genes in-
clude manganese superoxide dismutase (Wong et al., 1989)
and the zinc finger protein A20 (Opipari et al., 1992). Thus,
NF-
 
k
 
B activity can play a pivotal role in triggering anti-
apoptotic or proapoptotic pathways; however, the precise
factors that determine NF-
 
k
 
B’s ability to regulate these di-
vergent biological outcomes remain unclear.
Under basal nonstress conditions, NF-
 
k
 
B is sequestered
in most cells in the cytoplasm by a member of the I
 
k
 
B fam-
ily of proteins: I
 
k
 
B
 
a
 
, I
 
k
 
B
 
b
 
, or I
 
k
 
B
 
e
 
 (Baeuerle and Balti-
more, 1988; Baeuerle and Baltimore, 1996). Binding of
I
 
k
 
B to NF-
 
k
 
B masks nuclear localization signals on NF-
 
k
 
B
and prevents its translocation to the nucleus (Beg et al.,
1992). In response to a host of stimuli, including TNF-
 
a
 
,
virus infection, lipopolysaccharide, and UV light, I
 
k
 
B
 
a
 
 is
phosphorylated, followed by its degradation via the ubiq-
uitin–proteasome pathway (Henkel et al., 1993; Palom-
bella et al., 1994; Thanos and Maniatis, 1995; Chen et al.,
1996; DiDonato et al., 1995; DiDonato et al., 1996; DiDo-
nato et al., 1997; Régnier et al., 1997). Degradation of I
 
k
 
B
 
a 
 
allows free NF-
 
k
 
B to translocate to the nucleus to influ-
ence expression of its target genes. Degradation of I
 
k
 
B 
 
a
 
can be inhibited by mutating either serine 32 or 36 in the
NH
 
2
 
-terminal region of I
 
k
 
B 
 
a 
 
to alanines. (Brown et al.,
1995; Traenckner et al., 1995; DiDonato et al., 1996).
Overexpression of the 32A/36A NH
 
2
 
-terminal mutant
(I
 
k
 
B M) is an effective molecular strategy for suppressing
NF-
 
k
 
B activation in cultured cells (Wang et al., 1996). In-
deed, stable cell lines containing the superrepressor of NF-
 
k
 
B, I
 
k
 
B M have been generated and used to demonstrate
an antiapoptotic role for NF-
 
k
 
B activity in TNF 
 
a
 
, dauno-
rubicin, or UV irradiation–induced apoptosis (Wang et al.,
1996; van Antwerp et al., 1996). However, this approach
does not distinguish whether suppression of NF-
 
k
 
B activ-
ity must be initiated before or after the apoptotic stimulus
to regulate apoptosis.
To begin to address this question, we used the alphavi-
rus Sindbis virus, which induces apoptosis in cultured cells
(Levine et al., 1993) and in the brains of newborn mice
(Lewis et al., 1996). Like many other inducers of apopto-
sis, the precise mechanisms by which Sindbis virus (SV)
 
1
 
induces apoptosis is unknown, but many general antago-
nists of apoptosis, including Bcl-2 (Levine et al., 1993; Le-
 
vine et al., 1996), Bcl-X
 
L
 
 (Cheng et al., 1996), or the anti-
oxidant 
 
N
 
-acetylcysteine (NAC; Lin et al., 1995) can block
SV-induced death. Moreover, SV induces activation of
NF-
 
k
 
B via a classical ubiquitin–proteasome pathway many
hours in advance of morphological evidence of apoptosis
(Lin et al., 1998). Previous studies from our laboratory
demonstrated that NF-
 
k
 
B activity is required for cell
death in AT-3 prostate carcinoma cells (Lin et al., 1995),
but as with other studies, the NF-
 
k
 
B inhibitors were
present before the apoptotic stimulus was applied, and so
the role of SV-induced NF-
 
k
 
B activation in regulating apop-
tosis could not be directly assessed.
Recently, a recombinant form of SV has been developed
as a vector to express heterologous proteins after infection,
allowing their roles in SV-induced death to be examined
(Cheng et al., 1996). We used this vector to generate a re-
combinant SV that carries the superrepressor form of I
 
k
 
B 
 
a
 
.
Such a vector can not only elicit apoptosis, but can also in-
hibit nuclear NF-
 
k
 
B activity after, but not before infec-
tion. We report here that complete suppression of NF-
 
k
 
B
activation after SV infection neither suppresses nor poten-
tiates cell death. In contrast, stable expression of a super-
repressor form of I
 
k
 
B 
 
a 
 
in cell lines resulting in constitutive
suppression of NF-
 
k
 
B activation suppresses SV-induced
death. These data suggest that NF-
 
k
 
B activity induced by an
apoptotic stimulus such as SV infection does not influence
cell viability, while NF-
 
k
 
B activity before SV infection is
critical in regulating a proapoptotic response.
 
Materials and Methods
 
Culture and Viability Studies
 
AT-3 rat prostate carcinoma cells were cultured as previously described
(Lin et al., 1995) in RPMI 1640 medium containing 10% FCS, 2 mM 
 
l
 
-gluta-
mine, penicillin (50 U/ml), and streptomcyin (50 
 
m
 
g/ml). Wild-type, p65
knockout (p65
 
2
 
/
 
2
 
), and p50 knockout (p50
 
2
 
/
 
2
 
) 3T3 fibroblasts or EFs
(mouse embryonic fibroblasts) were cultured as previously described (Beg
and Baltimore, 1996). For viability studies, 10
 
3
 
 AT-3 cell/well or 10
 
4
 
mouse embryo fibroblasts/well were plated in 96-well dishes. One day af-
ter plating, SV (strain AR339) or recombinant SV (wild-type, M, or R)
were added at a multiplicity of infection of 10 plaque-forming units per
cell. Viability was assessed using a viability index generated by measuring
the cell-associated LDH activity (Promega Corp., Madison, WI) in SV-
infected cells and dividing this value by the cell-associated LDH activity in
mock-infected cells. In parallel, viability was also assessed by using the
metabolic label alamarBlue (Accu Med International, Chicago, IL) and
by making morphological observations of cell death using phase contrast
microscopy. Apoptotic cells were identified by the presence of phase
bright apoptotic bodies, or by pyknosis associated with membrane
blebbing. Previous studies have verified that these morphological changes
induced by SV in AT-3 cells are correlated with DNA laddering in multi-
mers of 185 bp, and hypercondensation and fragmentation of chromatin
characteristic of apoptosis (Lin et al., 1995).
For the cytotoxicity experiments involving TNF 
 
a 
 
(mouse; Boehringer
Mannheim Corp., Indianapolis, IN), 10
 
4
 
 AT-3 Zeo or AT-3 I
 
k
 
B Zeo cells
were seeded/well in a 96-well plate; for cytotoxicity experiments involving
H
 
2
 
O
 
2
 
, staurosporine 10
 
3
 
 AT-3 Zeo or AT-3 I
 
k
 
B Zeo cells were seeded/
well in a 96-well plate. In each of these death paradigms, viability was as-
sessed as described above.
 
Generation of Recombinant Sindbis Viruses 
Containing I
 
k
 
B wild-type (wt), I
 
k
 
B M, and I
 
k
 
B R
 
A fragment of hemagglutinin (HA; 3
 
3
 
)-tagged I
 
k
 
B 
 
a 
 
wt or an HA (3
 
3
 
)
tagged-I
 
k
 
B 
 
a 
 
with serines 32 and 36 mutated to alanines (M) was cut from
the HindIII/NotI sites of the corresponding Bluescript II Ks
 
1
 
 plasmids
(DiDonato et al., 1996). Each fragment containing I
 
k
 
B wt or I
 
k
 
B M was
 
1. 
 
Abbreviations in this paper
 
: EMSA, electrophoretic mobility shift assay;
HA, hemagglutinin; M, mutant; NAC, 
 
N
 
-acetylcysteine; R, reverse; SV,
Sindbis virus; STS, staurosporine; wt, wild-type.  
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blunt end–ligated into the BstEII site of a recombinant SV vector (ds
TE12Q) in forward and reverse orientations. The SV vectors containing
wild-type and mutated forms of HA-IkB a were linearized with PvuI and
transcribed in vitro with SP6 RNA polymerase (GIBCO BRL, Gaithers-
burg, MD). The resultant RNA transcripts were then transfected into
BHK cells using 10 mg of lipofectamine (GIBCO BRL) according to the
manufacturer’s instructions. 24 h after transfection, recombinant viruses
were harvested from the supernatant of the culture media of the trans-
fected BHK cells. Viral titers were determined by standard plaque assays
as previously described.
Electrophoretic Mobility Shift Assays (EMSAs)
Cytoplasmic and nuclear extracts were generated as previously described
(Lin et al., 1995). The protein concentration was determined by BCA as-
say (Pierce Chemical Co., Rockford, IL). Binding reactions for EMSA
were performed at room temperature for 15 min using 6–8 mg of nuclear
protein and 40,000 cpm (NF-kB) or 25,000 cpm (AP-1) of radiolabeled oli-
gonucleotide. DNA–protein complexes were separated from unbound
probe on native 5.3% polyacrylamide gels at 200–250 V for 2–3 h. The re-
sultant gel was vacuum-dried and exposed on film (Eastman Kodak Co.,
Rochester, NY) overnight at 2808C.
Immunoblot Analysis
20  mg of protein from cytoplasmic extracts were boiled in Laemmeli
buffer and electrophoresed under reducing conditions on 12% polyacryla-
mide gels. Proteins were then transferred to a polyvinylidene difluoride
membrane (Bio-Rad Laboratories, Hercules, CA). Nonspecific binding
was inhibited by incubation in Tris-buffered saline (TBST: 50 mM Tris-
HCl, pH 8.0, 0.9% NaCl, 0.1% Tween 20) containing 5% nonfat dried
milk for 2 h. Rabbit anti-IkB a antibody (C-21; Santa Cruz Biotechnology,
Santa Cruz, CA) and a polyclonal antibody recognizing Sindbis virus
structural proteins (a gift from Dr. Diane Griffin, The Johns Hopkins Uni-
versity School of Hygiene and Public Health) were diluted in 1% milk-
TBST at 1:1,000. Mouse anti-HA (12 CA5, Boehringer Mannheim) mono-
clonal antibody was diluted 1:1,000 in 1% milk TBST. After exposure of
membranes to HRP-conjugated anti-rabbit secondary antibody or HRP-
linked anti-mouse secondary antibody for 1.5 h, immunoreactive proteins
were detected according to the enhanced chemiluminescent protocol
(Amersham Corp., Arlington Heights, IL). For quantitiave analysis of IkB
a degradation after SV infection, secondary antibody incubation and im-
munocomplexes detection were performed according to the enhanced
chemiluminescent fluorescence protocol (Amersham Corp.).
Generation of AT-3 Cell Lines with Enforced 
Expression of IkBs
A HindIII/Not I fragment containing HA-tagged IkB M was blunt-ended
and ligated into the NheI site of an expression vector, pcDNA 3.1/Zeo
(Invitrogen, San Diego, CA). 2 mg of pcDNA 3.1/HA-IkB Zeo or empty
vector pcDNA 3.1/Zeo was transfected into AT-3 cells (2 3 105) using li-
pofectamine as described above. Resistant pools of clones containing the
transfected plasmids were selected with Zeocin (Invitrogen Corp.) at 350
mg/ml. Approximately 30 pools of clones (AT-3 IkB Zeo or AT-3 Zeo)
were isolated and expanded. Expression of IkB M in two independent
pools of clones was verified by immunoblotting using an anti-IkB a anti-
body as described above.
Luciferase Assays
105 AT-3 Zeo or AT-3 IkB Zeo cells were transfected using the lipo-
fectamine method, with 1.5 mg of SV40kB-luc reporter constructs (Ting et al.,
1996) along with 500 ng of pCMV-bgal plasmids. Luciferase activity was
determined 30 h after transfection, and was normalized on the basis of
b-galactosidase expression level. Both the luciferase assay system and
b-galactosidase assay system were purchased from Promega Corp.
Results
Inhibition of SV-induced NF-kB Activity in AT-3 Cells 
by Expression of IkB a in a Sindbis Virus Vector
To test whether SV-induced NF-kB activity is required for
SV-induced apoptosis, we generated a recombinant SV
that carries the wild-type IkB a gene (SV-IkB wt), or a
more stable mutant form of IkB a (SV-IkB M), each con-
taining three influenza virus HA epitope tags. As a con-
trol, we inserted the HA-tagged IkB wt in the reverse ori-
entation into the SV vector. Infection of AT-3 cells with
SV-IkB wt or SV-IkB M revealed the expression of HA-
tagged IkB 8 h after infection (Fig. 1, A and B). Using an
anti-HA antibody, we detected two bands reflecting HA-
IkBs that likely are translated from different initiation
sites within the HA-tagged region on the virus vector (Fig.
1 B). As expected, quantitative analysis of immunoblots
using ECF and phosphorimaging showed 20% greater lev-
els of HA-IkB in extracts from SV-IkB M–infected cells as
compared with extracts from SV-IkB wt-infected cells.
Additionally, overexpression of IkB by the vector SV
appeared to slow degradation of endogenous IkB a be-
cause we were able to detect modified, likely phosphory-
lated higher molecular weight forms of endogenous IkB a
in cytoplasmic extracts from cells infected with SV-IkB wt
and SV-IkB M, but not SV-IkB R-infected cells (Fig. 1 A).
Moreover 39, 25, and 37% of endogenous IkB a from AT-3
cells infected with SV-IkB wt, SV-IkB M, and SV-IkB R,
respectively, was degraded or converted to a modified
form 16 h after infection as compared with IkB a in mock-
infected cells (corresponding band is labeled by a star in
Fig. 1 A). Altogether, these data demonstrate that we are
able to express heterologous IkB wt and IkB M in AT-3
cells using the SV vector, and that, like the wild-type SV
(Lin et al., 1998), the recombinant SVs result in degrada-
tion of endogenous IkB a.
To determine whether the expressed IkBs are able to
suppress SV-induced NF-kB activity, we performed EMSAs
on nuclear extracts from infected and mock-infected cells
using a 32P-labeled probe with a consensus NF-kB binding
site. As shown in Fig. 1 D, 8 h after infection, SV-IkB R
elicited a dramatic increase in two NF-kB complexes, pre-
viously defined as p50–p65 and p50–p50 (Lin et al., 1995);
SV-IkB M completely suppressed p50–p65 activity and di-
minished p50–p50 activity; and SV-IkB wt induced a level
of p50–p65 activity intermediate between the SV-IkB M
and the SV-IkB R. The differences in NF-kB activity
among recombinant SV-IkBs was not due to their differ-
ent replication rates in AT-3 cells, because levels of SV
structural proteins (envelope glycoproteins, E1/E2, and
capsid proteins) were similar in cells infected with each re-
combinant virus (Fig. 1 C).
Complete Suppression of SV-induced NF-kB Activity 
Does Not Inhibit SV-induced Apoptosis in AT-3 Cells
We demonstrated that SV-induced NF-kB activity could
be suppressed using a recombinant SV containing a wt or
mutant form of IkB a. To determine the effects of sup-
pressing SV-induced NF-kB activity on apoptosis, we mea-
sured viability of cells infected with the different recombi-
nant viruses at several time points after infection. As
shown in Fig. 2, we found that SV-IkB wt, SV-IkB M, and
SV-IkB R triggered cell death with similar kinetics in AT-3
cells. Similar results were observed in BHK cells (data not
shown). These results suggest that SV-induced NF-kB ac-
tivity is not required for SV-induced apoptosis. However,The Journal of Cell Biology, Volume 141, 1998 1482
in a previous study we established that NF-kB is required
for SV-induced death by pretreating AT-3 cells with NF-
kB–specific transcription factor decoys that competitively
inhibit binding of NF-kB to its target DNA sites. To reconcile
these apparently conflicting observations, we hypothesized
that NF-kB activity before infection is necessary for SV-
induced apoptosis; that is, steady-state levels of NF-kB may
regulate expression of latent death genes before SV infection.
Stable Overexpression of IkB M in AT-3 Cells Delays 
SV-induced Apoptosis
AT-3 cells that overexpress IkB M were established to ex-
amine whether inhibition of NF-kB activity beginning be-
fore SV infection inhibits SV-induced death. Two pools of
cell clones stably expressing HA-tagged IkB M (AT-3 IkB
Zeo) were generated along with a pool of control clones
expressing a zeocin resistance gene product alone (AT-3
Zeo; Fig. 3 A). A pool of cell clones represents a popula-
tion of one or more individual clones. EMSA indicated
that IkB M overexpression in AT-3 cells functions as a su-
perrepressor because there was significant suppression of
NF-kB binding activity after SV infection in AT3-IkB Zeo
clones compared with the AT-3 Zeo cells (Fig. 3 B). A
slight induction of NF-kB activity 6 h after infection in the
AT-3 IkB cells was observed, likely due to the heteroge-
neous levels of HA-IkB M expression in our pool of AT-3
IkB clones.
AT-3 IkB Zeo cells that constitutively suppress NF-kB
activity are more resistant to SV-induced death than are
AT-3 Zeo cells (Fig. 3 C). The protection conferred by sta-
ble overexpression of IkB M could not be attributed to de-
creased viral entry or viral replication in these cells, be-
cause viral production measured 4 and 8 h after infection
was similar (P . 0.5) in AT-3 IkB Zeo and AT-3 Zeo cells
(data not shown). These results suggest that inhibition of
NF-kB activity beginning before, but not after SV infec-
tion prevents SV-induced death. Indeed, using a luciferase
reporter regulated by eight NF-kB binding sites, we found
nearly complete suppression of constitutive NF-kB activ-
ity in AT-3 IkB Zeo cells compared with AT-3 Zeo cells
(Fig. 3 D) or parental AT-3 cells (not shown).
Short-term Treatment of AT-3 Cells with
N-acetyl-L-cysteine Combined with Infection of
AT-3 Cells with SV-IkB M, but not SV-IkB R,
Prevents Cell Death
We next used a different approach to confirm that inhibi-
Figure 1. Inhibition of SV-induced NF-kB activity in AT-3 cells
by heterologous expression of the inhibitory subunit of NF-kB,
IkB a in a SV vector. (A–C) Cytoplasmic extracts were prepared
from AT-3 cells infected with SV-IkB wt, SV-IkB M, or SV-IkB
R at the time points indicated. A shows a Western blot analysis
against IkBa. HA-IkB corresponds to the heterologous HA-
tagged human IkB a; IkB corresponds to the endogenous IkB a;
endogenous nonphosphorylated IkB a and nonspecific bands are
denoted by an asterisk and N.S., respectively. (B) The blot shown
in  A was stripped, and anti-HA immunoreactive proteins are
shown. C shows the Western blot analysis against the sindbis vi-
rus structural proteins. The upper arrow points to the viral enve-
lope glycoproteins E1 and E2; the lower arrow points to the viral
capsid protein. (D) EMSA performed with 6–8 mg of nuclear ex-
tracts corresponding to cytoplasmic extracts used in A–C using a
32P-labeled oligonucleotide with a consensus NF-kB sequence
from the MHC class I promoter. Upper arrow points to the pre-
dominant complex induced by SV, p50-p65 heterodimer; the
lower arrow points to p50–p50 homodimers. The composition of
the induced NF-kB complexes were identified in a previous study
(Lin et al., 1995).
Figure 2. Cell viability of AT-3 cells infected with SV-IkB wt,
SV-IkB M, and SV-IkB R. Percent viability was determined 24
and 48 h after infection by the alamar blue assay. Results are ex-
pressed as the mean 6 SEM for experiments performed in tripli-
cate (P . 0.05). Error bars that did not show up are hidden by the
symbols.Lin et al. Steady-state NF-kB Activity Regulates SV-induced Apoptosis 1483
tion of NF-kB activity must be initiated in advance of the
apoptotic stimulus to prevent SV-induced death. In previ-
ous studies, we demonstrated that NAC at 30 mM pre-
vents SV-induced apoptosis without interfering with viral
replication (Lin et al., 1995). Therefore, we infected AT-3
cells with recombinant SV-IkBs in the presence of NAC.
In this way, we could suppress activation of apoptosis in-
duced by SV, but allow the recombinant SV to replicate
and concomitantly express the exogenous HA–tagged IkB
M. As expected, nearly complete survival was maintained
in SV-IkB M and SV-IkB R–infected cells in the presence
of 30 mM NAC (Fig. 4 A), and expression of HA-tagged
IkB M in the SV-IkB M–infected cells, but not the SV-IkB
R–infected cells, was verified by immunoblotting (data not
shown). After 19 h, the NAC was removed. The cells in-
fected with SV-IkB M were significantly protected from
cell death as compared with cells infected with SV-IkB R
24 and 48 h after NAC withdrawal (Fig. 4 A). AT-3 cells
that have been treated with NAC for 19 h appear to have
no defects in NF-kB activation, because 4 h after NAC
withdrawal, cells infected with SV-IkB R, but not the SV-
IkB M, elicited increased nuclear NF-kB activity (Fig. 4 B).
Embryonic Fibroblasts or 3T3 Cells
Derived from p652/2 Mice, but Not Embryonic 
Fibroblasts Derived from p502/2 Mice,
are Resistant to SV-induced Apoptosis
We next investigated whether inhibition of NF-kB activity
must be initiated before the apoptotic stimulus to observe
protection from SV-induced apoptosis in other cell types.
Cell survival was examined in primary embryonic fibro-
blasts (EFs) or immortalized fibroblasts (3T3) from p65
knockout (p652/2), p50 knockout (p502/2), and wt mice in-
fected with SV. Similar to our observations in AT-3 cells,
SV-IkB wt, SV-IkB M, and SV-IkB R induced death in 3T3
cells with identical kinetics (Fig. 5 A). In contrast, p652/2
3T3 cells, but not p502/2 3T3 cells, were more resistant to
SV-induced apoptosis than the wt 3T3 cells. These effects
are unlikely to be due to secondary changes resulting from
immortalization, because EFs from p652/2 mice, but not
p502/2 mice, showed significant protection from SV-induced
cell death as well (Fig. 5 B). Viral titers determined from the
infected cell supernatant of wt 3T3 cells and p652/2 3T3 cells
4, 8, and 12 h after infection indicated that SV was replicat-
ing equally well in both cells (P . .05; data not shown).
Figure 3. The effect of stable overexpression of IkB a M on SV-induced apoptosis in AT-3 cells. (A) Western blot analysis demonstrat-
ing expression of HA-tagged IkB M in two pools of AT-3 IkB Zeo cell clones, but not in the corresponding AT-3 cells containing the
zeocin resistance gene alone. (B) EMSA was performed using nuclear extracts obtained in parallel from SV-infected AT-3 Zeo or AT-3
IkB Zeo cells O, 4, and 6 h after infection. The upper arrow points to the p50–p65 complex, and the lower arrow points to p50–p50 ho-
modimers. (C) Cell viability of AT-3 Zeo and AT-3 IKB Zeo cells 40 h after SV infection. Viability was determined by LDH assay as
described in Materials and Methods. and is expressed as mean 6 SEM for three separate experiments (P , 0.005). (D) Basal level of
NF-kB transcriptional activity was nearly completely suppressed in AT-3 IkB Zeo cells compared with AT-3 Zeo cells. Basal level of
NF-kB activity was determined by kB luciferase reporter system (P , 0.005).The Journal of Cell Biology, Volume 141, 1998 1484
Altogether, data from AT-3 prostate carcinoma cells
and mouse embryo fibroblasts experiments argue that in-
hibition of NF-kB activity must be initiated before SV in-
fection to suppress cell death, while inhibition of SV-induced
NF-kB activity alone neither potentiates nor inhibits SV-
induced death.
The Proapoptotic and Antiapoptotic Roles of NF-kB are 
Determined by the Death Stimulus
Our observations that fibroblasts from p652/2 mice are
more resistant to SV–induced apoptosis are in contrast to
previous observations that TNF a–induced apoptosis is po-
tentiated in fibroblasts from p652/2 mice (Beg and Balti-
more, 1996). These results suggest that the proapoptotic or
antiapoptotic roles of NF-kB are determined by the death
stimulus, and are not necessarily dependent on the cell
type. To examine this possibility further, we compared via-
bilities in populations of AT-3 Zeo and AT-3 IkB M
clones in response to a broad range of cytotoxic stimuli, in-
cluding hydrogen peroxide (H2O2), TNF a, the general
protein kinase inhibitor staurosporine (STS), and serum
deprivation. Similar to SV infection, we found that cell
death induced by 100 mM (not shown) or 500 mM peroxide
was delayed in two populations of IkB M overexpressing
cell clones as compared with control cells (Fig. 6 A); thus,
in addition to SV infection, NF-kB also appears to exhibit
prodeath activity after peroxide treatment. In contrast
Figure 4. Short-term treatment of AT-3 cells with N-acetyl-l-cys-
teine (NAC) combined with infection with SV-IKB M, but not
SV-IKB R, prevents cell death. (A) 2.5 3 103 cells/well in 96-well
plates were infected with SV-IkB M or SV-IkB R, and were
treated with 30 mM NAC for 19 h. The cells were washed twice
with PBS, and fresh media without NAC was added. Cell viability
was determined by the alamar blue assay 0, 24, and 48 h after
NAC withdrawal. Results are expressed as the mean 6 SEM for
three experiments (P , 0.005) 24 and 48 hours after NAC with-
drawal. (B) EMSAs were performed on nuclear extracts from
SV-IkB M and SV-IkB R–infected cells 4 h after NAC with-
drawal using 6–8 mg of protein and radiolabeled NF-kB or AP-1
probes. The quality of the nuclear exatracts from the treated and
infected cells was confirmed by analysis of AP-1 DNA activity,
indicating that NAC does not interfere with global nuclear pro-
tein activity. The arrow points to the NF-kB p50–p65 complex;
the lower band is the NF-kB p50–p50 complex.
Figure 5. Cell viability of wt, p65 knockout, and p50 knockout
embryo fibroblasts. (A) Viability of wt 3T3 cells infected with
SV-IkB wt, SV-IkB M, and SV-IkB R 24 h after infection (P .
0.05). (B) Viability of wt, p652/2, and p502/2 3T3 cells and EFs
infected with wt SV 24 h after infection. 3T3 refers to immortal-
ized fibroblasts, while EFs refers to primary fibroblasts. Viability
was determined by LDH assay as described in Materials and
Methods and normalized to identical cell densities among the
three cell types. Results are expressed as mean 6 SEM for 3–5
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(and in agreement with observations from others; Liu et
al., 1996; Beg and Baltimore, 1996; Wang et al., 1996; van
Antwerp et al., 1996), exposure of AT3-IkB M cells to
TNF a (10 ng/ml) or staurosporine (STS at 100 nM or 2
mM) results in significantly greater levels of cell death than
AT3-Zeo cells exposed to each of these stimuli (Fig. 6, B
and C). Finally, AT-3 Zeo or AT-3 IkB cells died at simi-
lar rates (P . 0.1) in response to 48 h of serum deprivation
(Table I). These observations support the notion that the
death stimulus is critically important in determining whether
NF-kB regulates prodeath, antideath proteins, or is an in-
nocent bystander.
Discussion
Elucidation of the signaling pathways leading to activation
of NF-kB, the precise identity of NF-kB family members,
and definition of consensus DNA-binding sequences of
this family of DNA-binding proteins have provided pow-
erful molecular tools for suppressing nuclear NF-kB activ-
ity in intact cells, and in evaluating the role of NF-kB in
apoptosis (Abbadie et al., 1993; Barger et al., 1995; Lin et
al., 1995; Beg and Baltimore, 1996; Wang et al., 1996; van
Antwerp et al., 1996). In each of these studies, deletion of
individual NF-kB subunits or expression of inhibitors of
NF-kB nuclear activity were initiated before the apoptotic
stimulus, so it could not be determined if the critical cell
death regulatory function(s) of NF-kB activity occur be-
fore or after the death stimulus. Indeed, in previous stud-
ies we showed that suppression of SV-induced NF-kB ac-
tivity by pretreatment with NF-kB–specific transcription
factor decoys inhibits SV-induced apoptosis (Lin et al.,
1995). Our previous results could not distinguish between
two likely models (Fig. 7). In the first model (see Fig. 7 A),
SV induces degradation of IkB, leading to translocation of
NF-kB to the nucleus and expression of one or more kB-
dependent death proteins. In the second model (see Fig. 7
B), nuclear NF-kB activity occurring at some time before
the SV infection is required for expression of a protein in-
volved in apoptosis that is directly or indirectly activated
by SV infection. In the second scheme, SV-induced NF-kB
activity could be involved in regulating responses not di-
rectly related to cell death, such as the inflammatory re-
sponse. Herein, we show that a recombinant SV carrying a
superrepressor form of IkB a suppresses SV-induced NF-
kB nuclear activity (Fig. 1), but does not inhibit or potenti-
ate apoptosis in AT-3 prostate carcinoma cells (Fig. 2) or
3T3 embryo fibroblasts (Fig. 5 A). These results, combined
with our observations that AT-3 cells stably overexpress-
ing the superrepressor of NF-kB (Fig. 3) or mouse embryo
fibroblasts deleted in the p65 subunit of NF-kB (Fig. 4) are
more resistant to SV-induced death, are consistent with
the second model. Furthermore, these data imply a re-
quirement for a p65-containing NF-kB complex to drive
expression of an essential gene for SV-induced cell death.
If Sindbis-virus–induced NF-kB activation is not an im-
portant determinant in cell viability, what is the stimulus
before infection leading to NF-kB–dependent synthesis of
prodeath proteins? Several lines of evidence have demon-
strated that NF-kB activity can be modulated during cell
cycle progression (Baldwin et al., 1991; Li et al., 1993;
Evans et al., 1993; Duckett et al., 1995; Bash et al., 1997).
In quiescent 3T3 fibroblasts, NF-kB is quickly induced by
stimulation with serum or growth factors as cells transition
from G0 to G1 stages of the cell cycle (Duckett et al., 1995).
Moreover, specific cyclin-dependent kinases were shown
to regulate transcriptional activation by NF-kB through
the interaction with the coactivator p300 (Perkins et al.,
1997). Thus, a cell cycle–dependent NF-kB activity could
be activated before infection. Such an activity may be un-
detectable by EMSA (Fig. 1 D and Fig. 3 B), but detect-
able by NF-kB reporter gene assay (Fig. 3 D), which is
more sensitive. The inability to detect NF-kB DNA bind-
ing may be due to the unsynchronized nature of the popu-
lation of cells we study, or because cell cycle–dependent
activation of NF-kB– dependent genes occurs as a result
of phosphorylation of nuclear p65-containing complexes
without enhanced nuclear translocation of NF-kB (Finco
et al., 1997). We speculate that the cell cycle–dependent
Figure 6. The effect of overexpression of IkB M on H2O2-, TNF a-,
and STS-induced death in AT-3 cells. Cell viability was deter-
mined by LDH assay as described in Materials and Methods, and
results are expressed as mean 6 SEM for three separate experi-
ments. AT-3 Zeo or AT-3 IkB Zeo cells exposed to: (A) 500 mM
peroxide for 4 h (P , 0.005), (B) TNF-a (10 ng/ml) for 24 h (P ,
0.005), and (C) 100 nM or 2 mM STS for 24 or 48 h (P , 0.005).
Table I. The Role of NF-kB in Regulating Apoptosis in AT-3 
Cells Depends on the Death Stimulus
Stimulus Proapoptotic Antiapoptotic
SV 12
H 2 O 2  (100 mM and 500 mM) 12
TNF (10 ng/ml) 21
STS (100 nM and 2 mM) 21
Serum deprivation (48 h) 22The Journal of Cell Biology, Volume 141, 1998 1486
activation of NF-kB may regulate expression of inactive
forms of one or more apoptotic effectors or regulators be-
fore the apoptotic stimulus. Of note, previous studies have
shown that inducible expression of a dominant negative
Ras inhibits cell cycle progression and SV-induced apop-
tosis, while infection of PC12 cells with recombinant SV
carrying a dominant negative Ras has no effect on viability
(Joe et al., 1996). These findings, along with data pre-
sented herein and recent observations demonstrating that
oncogenic Ras activates NF-kB–dependent gene expres-
sion, are consistent with the following model: a cell cycle–
dependent Ras-induced signal transduction pathway acti-
vates NF-kB that regulates the expression of proapoptotic
genes before SV infection.
How can the proapoptotic role of NF-kB in the setting
of SV infection be reconciled with the established antiapop-
totic role of NF-kB in response to other apoptotic stimuli?
The stimulus, the cell type, and the subunit of NF-kB acti-
vated have all been proposed as critical factors that deter-
mine whether this transcription factor promotes or sup-
presses apoptosis. We provide evidence suggesting that
the stimulus may be the main factor in determining NF-
kB’s ability to regulate divergent biological outcomes.
First, overexpression of IkB M in AT-3 cells protects from
SV and H202-induced cell death, but potentiates TNF-a
and staurosporine-induced cell death, indicating that sup-
pression of NF-kB activity can be proapoptotic or antiapop-
totic in the same cell type, depending on the stimulus. Sec-
ond, fibroblasts from p652/2mice, but not p502/2 mice, are
resistant to SV-induced death, but more sensitive to TNF-
a–induced death. These observations show that the de-
leted subunit of NF-kB is required for specific target gene
activation leading to either a pro- or antiapoptotic re-
sponse, but is not a necessary determinant in the proapop-
totic or antiapoptotic actions of NF-kB. Finally, our obser-
vation that serum deprivation–induced death occurs with
similar kinetics in AT-3 Zeo and AT-3 IkB Zeo cells sug-
gests that NF-kB is not part of this common pathway of
apoptotic death, and that other stimulus-specific pathways
may need to be simultaneously activated to determine NF-
kB’s role in determining cell survival or death.
Our results are congruent with the emerging concept of
private cell death pathways (Smith and Osborne, 1997).
This notion acknowledges the existence of a common ef-
fector phase to apoptotic cell death, but states that within
a given cell, many stimuli are capable of inducing apopto-
sis, and that each stimulus may do so by inducing a unique
set of genes. These genes in turn may positively or nega-
tively regulate activation of the common effector pathway.
Heretofore, the best-studied examples of stimulus-specific
cell death pathways have been in lymphocytes, where ion-
izing radiation (Lowe et al., 1993), glucocorticoids (Liu et
al., 1994), and T cell activation (Woronicz et al., 1994)
each activate unique transcription factor responses that
converge on a common final effector pathway to apopto-
sis. Our studies carry this concept a step further, and sug-
gest that a single transcription factor, NF-kB, can mediate
activation or suppression of cell death signals in the same
cell type depending on the stimulus (Fig. 6; Table I). Fur-
thermore, we identify that timing of NF-kB activation is
another important variable in determining whether this
transcription factor regulates expression of prodeath pro-
teins, or is an innocent bystander (Figs. 2, 3 C, and 5). The
demonstration herein that steady-state NF-kB activity is
required to promote SV-induced cell death in AT-3 pros-
tate carcinoma cells and 3T3 fibroblasts will focus future
studies aimed at defining one or more NF-kB–regulated
genes required for SV-induced apoptosis.
Accumulating evidence indicates that apoptosis results
from activation of a constitutively expressed suicide pro-
gram that is conserved in evolution from nematodes to hu-
mans (Steller, 1995; Martin and Green, 1995). Interest-
ingly, in prokaryotes such as Escherichia coli, a protease
whose specific substrate is the translational elongation fac-
tor EF-Tu, is constitutively expressed. During infection
with bacteria phage, this protease is activated and cleaves
EF-Tu, leading to death of the cells (Snyder, 1995; Jacob-
son et al., 1997). Our findings suggest a parallel example in
mammalian cells where SV infection posttranscriptionally
or posttranslationally activates a constitutively expressed
suicide program that is regulated in part, by NF-kB before
infection.
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